Wellington Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $334M | Sell |
5,506,996
-1,414,512
| -20% | -$82.5M | 0.06% | 266 |
|
|
2025
Q4 | $373M | Sell |
6,921,508
-10,234,541
| -60% | -$492M | 0.07% | 253 |
|
|
2025
Q3 | $774M | Sell |
17,156,049
-8,667,308
| -34% | -$405M | 0.14% | 163 |
|
|
2025
Q2 | $1.2B | Buy |
25,823,357
+2,094,914
| +9% | +$103M | 0.22% | 108 |
|
|
2025
Q1 | $1.45B | Buy |
23,728,443
+17,750,938
| +297% | +$1.03B | 0.28% | 87 |
|
|
2024
Q4 | $338M | Buy |
5,977,505
+5,827,317
| +3,880% | +$326M | 0.06% | 255 |
|
|
2024
Q3 | $7.77M | Sell |
150,188
-16,518
| -10% | -$775K | ﹤0.01% | 1236 |
|
|
2024
Q2 | $6.92M | Sell |
166,706
-120,301
| -42% | -$5.38M | ﹤0.01% | 1250 |
|
|
2024
Q1 | $15.6M | Sell |
287,007
-4,035,525
| -93% | -$206M | ﹤0.01% | 1006 |
|
|
2023
Q4 | $222M | Sell |
4,322,532
-235,872
| -5% | -$12.4M | 0.04% | 370 |
|
|
2023
Q3 | $265M | Sell |
4,558,404
-40,429
| -0.9% | -$2.48M | 0.05% | 312 |
|
|
2023
Q2 | $294M | Sell |
4,598,833
-29,568
| -0.6% | -$1.98M | 0.06% | 310 |
|
|
2023
Q1 | $321M | Sell |
4,628,401
-4,291,087
| -48% | -$303M | 0.06% | 283 |
|
|
2022
Q4 | $642M | Sell |
8,919,488
-24,466,468
| -73% | -$1.84B | 0.13% | 162 |
|
|
2022
Q3 | $2.37B | Sell |
33,385,956
-2,374,239
| -7% | -$172M | 0.51% | 49 |
|
|
2022
Q2 | $2.75B | Sell |
35,760,195
-6,761,865
| -16% | -$515M | 0.55% | 45 |
|
|
2022
Q1 | $3.11B | Sell |
42,522,060
-7,625,459
| -15% | -$512M | 0.53% | 47 |
|
|
2021
Q4 | $3.13B | Buy |
50,147,519
+4,740,155
| +10% | +$278M | 0.5% | 50 |
|
|
2021
Q3 | $2.69B | Buy |
45,407,364
+1,444,304
| +3% | +$95.1M | 0.46% | 53 |
|
|
2021
Q2 | $2.94B | Buy |
43,963,060
+1,084,441
| +3% | +$70.7M | 0.49% | 45 |
|
|
2021
Q1 | $2.71B | Sell |
42,878,619
-2,864,856
| -6% | -$178M | 0.48% | 50 |
|
|
2020
Q4 | $2.84B | Sell |
45,743,475
-8,244,932
| -15% | -$507M | 0.52% | 43 |
|
|
2020
Q3 | $3.25B | Sell |
53,988,407
-9,663,365
| -15% | -$582M | 0.67% | 32 |
|
|
2020
Q2 | $3.74B | Sell |
63,651,772
-11,856,489
| -16% | -$709M | 0.83% | 26 |
|
|
2020
Q1 | $4.21B | Sell |
75,508,261
-7,962,616
| -10% | -$487M | 1.11% | 13 |
|
|
2019
Q4 | $5.36B | Sell |
83,470,877
-26,185,727
| -24% | -$1.5B | 1.12% | 12 |
|
|
2019
Q3 | $5.56B | Sell |
109,656,604
-3,928,894
| -3% | -$185M | 1.25% | 9 |
|
|
2019
Q2 | $5.15B | Sell |
113,585,498
-11,950,250
| -10% | -$557M | 1.14% | 10 |
|
|
2019
Q1 | $5.99B | Sell |
125,535,748
-9,763,531
| -7% | -$486M | 1.36% | 5 |
|
|
2018
Q4 | $7.03B | Sell |
135,299,279
-6,368,988
| -4% | -$342M | 1.76% | 3 |
|
|
2018
Q3 | $8.79B | Buy |
141,668,267
+45,074
| +0% | +$2.67M | 1.85% | 2 |
|
|
2018
Q2 | $7.84B | Buy |
141,623,193
+1,966,533
| +1% | +$106M | 1.74% | 3 |
|
|
2018
Q1 | $8.83B | Buy |
139,656,660
+1,584,361
| +1% | +$102M | 2% | 1 |
|
|
2017
Q4 | $8.46B | Sell |
138,072,299
-9,529,453
| -6% | -$596M | 1.87% | 2 |
|
|
2017
Q3 | $9.41B | Sell |
147,601,752
-3,393,577
| -2% | -$198M | 2.16% | 1 |
|
|
2017
Q2 | $8.41B | Sell |
150,995,329
-1,542,940
| -1% | -$84M | 1.98% | 1 |
|
|
2017
Q1 | $8.3B | Buy |
152,538,269
+4,295,831
| +3% | +$236M | 2% | 1 |
|
|
2016
Q4 | $8.66B | Buy |
148,242,438
+11,818,681
| +9% | +$646M | 2.17% | 1 |
|
|
2016
Q3 | $7.36B | Buy |
136,423,757
+6,808,847
| +5% | +$437M | 1.84% | 3 |
|
|
2016
Q2 | $9.53B | Sell |
129,614,910
-7,312,300
| -5% | -$517M | 2.46% | 2 |
|
|
2016
Q1 | $8.75B | Sell |
136,927,210
-777,341
| -0.6% | -$49M | 2.3% | 2 |
|
|
2015
Q4 | $9.47B | Sell |
137,704,551
-3,880,657
| -3% | -$256M | 2.48% | 2 |
|
|
2015
Q3 | $8.38B | Buy |
141,585,208
+3,190,896
| +2% | +$202M | 2.34% | 2 |
|
|
2015
Q2 | $9.21B | Sell |
138,394,312
-815,789
| -0.6% | -$53.8M | 2.38% | 2 |
|
|
2015
Q1 | $8.98B | Buy |
139,210,101
+4,058,109
| +3% | +$254M | 2.31% | 2 |
|
|
2014
Q4 | $7.98B | Buy |
135,151,992
+730,973
| +0.5% | +$41.2M | 2.11% | 2 |
|
|
2014
Q3 | $6.88B | Buy |
134,421,019
+14,474,052
| +12% | +$723M | 1.9% | 3 |
|
|
2014
Q2 | $5.82B | Buy |
119,946,967
+30,778,426
| +35% | +$1.52B | 1.57% | 4 |
|
|
2014
Q1 | $4.63B | Buy |
89,168,541
+9,630,338
| +12% | +$512M | 1.29% | 6 |
|
|
2013
Q4 | $4.23B | Buy |
79,538,203
+814,677
| +1% | +$41.5M | 1.22% | 7 |
|
|
2013
Q3 | $3.64B | Buy |
78,723,526
+19,398,830
| +33% | +$852M | 1.14% | 8 |
|
|
2013
Q2 | $2.65B | Buy |
+59,324,696
| New | +$2.58B | 0.87% | 16 |
|
Other funds holding BMY
VCM
VPM
Wellington Management Group's BMY Position: Q1 2026 in Review
Wellington Management Group reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, selling an estimated $82.5M and leaving 5,506,996 shares worth $334M. The position accounts for 0.06% of the portfolio, ranked #266.
Wellington Management Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.53B in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wellington Management Group held 5,506,996 shares of Bristol-Myers Squibb worth $334M as of Q1 2026.
- Wellington Management Group sold 1,414,512 Bristol-Myers Squibb shares in Q1 2026, an estimated $82.5M.
- Bristol-Myers Squibb made up 0.06% of Wellington Management Group's portfolio in Q1 2026, its #266 holding.
- Wellington Management Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Wellington Management Group's Bristol-Myers Squibb position peaked at $9.53B in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.